NovaBridge Biosciences (FRA:0VY)
Germany · Delayed Price · Currency is EUR 2.180
-0.060 (-2.68%)
At close: Mar 27, 2026
NovaBridge Biosciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
254.18M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 632.00K | 2.18M | - |
| Dec 31, 2022 | -1.55M | -15.41M | - |
| Dec 31, 2021 | 13.86M | -222.44M | -94.14% |
| Dec 31, 2020 | 236.29M | 231.99M | 5,384.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biotest Aktiengesellschaft | 635.20M |
| 2invest AG | 28.07M |
| Darwin AG | 27.35M |
| Paion AG | 14.81M |
| co.don AG | 6.24M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 57.01K |
| bioXXmed AG | 20.49K |